Progyny, Inc. (PGNY) is a Healthcare stock trading at $26.07 (as of 2026-06-18), with a market capitalization of $2.00B and a trailing P/E of 33.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Progyny, Inc. provides employer benefits solutions focused on fertility and family building in the United States. Its offerings include fertility benefits with plan design and member support via a specialist network, an integrated pharmacy benefits component (Progyny Rx), and reimbursement programs for surrogacy and adoption.